BALTIMORE, Sept. 7 /PRNewswire/ -- Alba Therapeutics Corporation today announced the appointment of Betsy Van Parijs, M.D., Ph.D. to Senior Vice President, Clinical Development and Medical Affairs. In this role, Dr. Van Parijs will be responsible for leading Alba's clinical development strategy and program execution through product approval and commercialization. Dr. Van Parijs will also serve as a member of Alba's executive management leadership team.
"We are very pleased to announce that Dr. Van Parijs is joining Alba in this critical leadership role. Betsy is an accomplished executive with extensive experience in clinical development including the development, execution and validation of a patient-reported outcomes (PRO) instrument as a new primary efficacy endpoint for clinical trials," said Blake Paterson, M.D., Alba's Chief Executive Officer. "Her leadership in our efforts to validate the celiac disease activity rating score in our upcoming Phase II clinical trials will be essential for the success of AT-1001 as the first drug for celiac disease," added Dr. Paterson.
"Alba has a singular approach to the treatment of seemingly diverse clinical syndromes. Its discovery engine and clinical path offer the promise of redefining the pathogenesis and treatment of certain autoimmune diseases. I am delighted to join such a dedicated and innovative organization," said Dr. Van Parijs.
Prior to joining Alba, Dr. Van Parijs held senior level positions in
clinical development (phases II-IV) and medical affairs at two
multinational pharmaceutical companies. From 2003 to 2007, Dr. Van Parijs
served as Senior Director, Clinical Development and Medical Affairs in the
Infectious Diseases Center (Anti-Infectives) at GlaxoSmithKline (GSK) where
she was responsible for directing the clinical sections of regulatory
submissions, defining and implementing later phase clinical strategy for
Anti-Infectives in the pipeline, and for medical affairs, including
|SOURCE Alba Therapeutics Corporation|
Copyright©2007 PR Newswire.
All rights reserved